Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
307,102,100
-
Shares change
-
+9,649,649
-
Total reported value, excl. options
-
$3,857,183,589
-
Value change
-
+$125,609,285
-
Put/Call ratio
-
40%
-
Number of buys
-
104
-
Number of sells
-
102
-
Price
-
$12.56
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2023
As of 30 Jun 2023 AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) had 262 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 307,102,100 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, MORGAN STANLEY, STATE STREET CORP, and Palo Alto Investors LP.
This table shows 262 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.